FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 4 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It would be hard to recommend this as a single-dose vaccine at this point.” The FDA isn’t bound by the recommendation as it makes a final decision – and adding to the debate’s complexity, new research also suggests that J&J recipients might have a stronger immune response if their booster dose is from a competing brand. But J&J’s vaccine has consistently shown lower effectiveness levels across a series of studies – and the FDA panel ultimately settled on another shot for any recipient 18 or older at least two months after their first vaccination. “And that is a finding of concern particularly because that’s been seen in minority communities potentially and others.” As for its booster, J&J presented results from a large study that found giving a second dose just two months after the first bumped protection against symptomatic COVID-19 to 94% from 70% in U.S. recipients.

Shot Months Fda Moderna Booster Pfizer Dose Vaccine Fda Scientists  covid19  fda  endorses  shot  booster  moderna  protection  months  jj  recipients  dose  vaccine  panel

History of this topic

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
6 months, 1 week ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
9 months, 1 week ago

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Government advisers Wednesday said it’s …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
9 months, 1 week ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 2 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Should you get the new COVID booster? The CDC is about to decide
1 year, 6 months ago

Should you get the new COVID booster? The CDC is about to decide

LA Times  

A nurse prepares a syringe of a COVID-19 vaccine. The CDC’s vaccine advisors will soon decide whether to recommend the latest COVID-19 boosters only for frail, older, sick and immunocompromised people or to offer it to everyone over 6 months of age. “I don’t plan to get it myself,” said Dr. Paul Offit, the director of the Vaccine Education Center …

FDA’s advisors back plan to simplify COVID-19 vaccinations
2 years, 1 month ago

FDA’s advisors back plan to simplify COVID-19 vaccinations

LA Times  

Syringes with COVDI-19 vaccines are prepared at a free public clinic in Lynwood last year. “We’re still protected against severe disease, thank goodness,” even after the latest Omicron strains cropped up, said FDA advisor Dr. Paul Offit, a vaccine expert at Children’s Hospital of Philadelphia. The first step: The FDA advisory panel voted unanimously that people should get the same …

FDA proposes once-a-year COVID-19 shots for most Americans
2 years, 1 month ago

FDA proposes once-a-year COVID-19 shots for most Americans

LA Times  

U.S. health officials are proposing a simplified approach to COVID-19 vaccinations for most adults and children. That baseline of protection should be enough to move to an annual booster against the latest strains in circulation and make COVID-19 vaccinations more like the yearly flu shot, according to the agency. FDA scientists and vaccine companies would study vaccination, infection rates and …

'Consider 2nd Booster': A Request Given to Mansukh Mandaviya During Covid-19 Meeting with Doctors
2 years, 2 months ago

'Consider 2nd Booster': A Request Given to Mansukh Mandaviya During Covid-19 Meeting with Doctors

News 18  

Union health minister Mansukh Mandaviya has been urged to consider a second booster dose for Covid-19, especially for healthcare workers and frontline workers. According to a Deutsche Welle article published in January, a study conducted in Israel suggested that fourth dose of the coronavirus vaccine does not offer significant protection from the Omicron variant. Sarah Fortune, John LaPorte Given Professor …

As COVID-19 spikes in California, booster shots could make all the difference
2 years, 3 months ago

As COVID-19 spikes in California, booster shots could make all the difference

LA Times  

With coronavirus cases and hospitalizations rising in Los Angeles County, officials are voicing new confidence in the effectiveness of the updated COVID-19 booster shot. New data has found that the updated COVID-19 vaccines offer “significant additional protection” against symptomatic infection in people who were previously vaccinated or boosted with the older formula. “We have seen very low uptake of the …

CDC Advisers Weigh Who Needs Updated COVID Booster And When
2 years, 6 months ago

CDC Advisers Weigh Who Needs Updated COVID Booster And When

Huff Post  

LOADING ERROR LOADING COVID-19 boosters updated to match the newest omicron strains are about to roll out, and government advisers met Thursday to decide who should roll up their sleeves ― and when. The original COVID-19 vaccines still offer strong protection against severe illness and death, especially among younger and healthier people who’ve gotten at least one booster. The new …

J&J COVID vaccine factory forced to trash even more doses
2 years, 7 months ago

J&J COVID vaccine factory forced to trash even more doses

Associated Press  

WASHINGTON — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how more than 400 million vaccine doses made at an Emergent BioSolutions plant had to be trashed. Johnson & …

US health officials urge booster shots as COVID variants spread
2 years, 8 months ago

US health officials urge booster shots as COVID variants spread

Al Jazeera  

The administration of US President Joe Biden pushes vaccines as the best way to avoid potential disruptions from new BA.4 and BA.5 variants. “Staying up to date on your COVID-19 vaccines provides the best protection against severe outcomes.” Walensky said the US has seen a doubling in the number of hospitalisations due to COVID-19 since April, reflecting the spread of …

FDA advisers recommend updating COVID booster shots for fall
2 years, 8 months ago

FDA advisers recommend updating COVID booster shots for fall

Associated Press  

At least some U.S. adults may get updated COVID-19 shots this fall, as government advisers voted Tuesday that it’s time to tweak booster doses to better match the most recent virus variants. Their combination shots, what scientists call “bivalent” vaccines, substantially boosted levels of antibodies capable of fighting that variant, more than simply giving another dose of today’s vaccine. Marks …

FDA advisors recommend updating COVID booster shot formula for fall
2 years, 8 months ago

FDA advisors recommend updating COVID booster shot formula for fall

LA Times  

Advisors to the Food and Drug Administration are recommending that some U.S. adults get a modified COVID-19 booster shot this fall that better matches the recent variants. Some U.S. adults are a step closer to getting updated COVID-19 boosters this fall, as government advisors voted Tuesday that it’s time to tweak the shots to better match the most recent virus …

WHO Says Second Booster Jab Beneficial For Vulnerable Population
2 years, 9 months ago

WHO Says Second Booster Jab Beneficial For Vulnerable Population

News 18  

An expert group convened by the World Health Organization says there may be some benefit in giving a second booster dose of coronavirus vaccine to the most vulnerable people amid the continuing global spread of omicron and its subvariants. The WHO said its expert group had assessed the limited data from seven studies for second booster doses of messenger RNA …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 10 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds
2 years, 10 months ago

AstraZeneca Covid Booster Shot Effective Against Severe Disease, UK Study Finds

News 18  

London: The third dose of AstraZeneca COVID-19 vaccine is effective against symptomatic disease and hospitalisation, offering protection comparable to a booster shot of the Pfizer preventive, according to a study conducted in the UK. The results show that after 25 or more weeks since primary vaccination with AstraZeneca, vaccine effectiveness against symptomatic disease post Omicron infection was 8.0 per cent …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 10 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

Now is the time to get a second COVID booster shot, L.A. County says
2 years, 11 months ago

Now is the time to get a second COVID booster shot, L.A. County says

LA Times  

President Biden receives his second COVID-19 vaccine booster shot at the White House on Wednesday. Here’s everything you need to know about the state of the pandemic and the second COVID-19 booster shot: Why was a second booster shot made available? People age 50 and up are able to get a second COVID-19 booster shot once they’re at least four …

US regulators approve 2nd COVID booster for those aged 50 and up
2 years, 11 months ago

US regulators approve 2nd COVID booster for those aged 50 and up

Al Jazeera  

US has seen a small uptick in new COVID-19 cases during the past week, raising concern that infections could surge again. Regulators in the United States have authorised another COVID-19 booster shot for people aged 50 and older, amid concerns that coronavirus infections may begin rising again due to waning immunity to Omicron variants. “Based on an analysis of emerging …

FDA and CDC sign off on second Pfizer or Moderna booster shot for people 50 and older
2 years, 11 months ago

FDA and CDC sign off on second Pfizer or Moderna booster shot for people 50 and older

LA Times  

The Food and Drug Administration has authorized another booster dose of the Pfizer and Moderna COVID-19 vaccines for people age 50 and up. U.S. regulators Tuesday authorized an additional COVID-19 booster shot for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds. The Food and Drug Administration’s decision allows …

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients
3 years ago

J&J vaccine recipients were FIVE TIMES as likely to be hospitalized with Covid as Pfizer recipients

Daily Mail  

The Johnson & Johnson COVID-19 vaccine was not nearly as effective as its peers at preventing hospitalization from the virus, a new study of elderly patients finds. A French research team found that 28 days after administration of the single-dose J&J shot, and the second dose of the Pfizer-BioNTech vaccine, the J&J recipients were 5.2 times more likely to be …

Johnson & Johnson recipients can get third COVID shot in San Francisco
3 years, 1 month ago

Johnson & Johnson recipients can get third COVID shot in San Francisco

LA Times  

San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna. The allowance of a potential third dose to J&J recipients in San Francisco goes beyond the guidance outlined …

US FDA gives full approval to Moderna’s COVID vaccine
3 years, 1 month ago

US FDA gives full approval to Moderna’s COVID vaccine

India TV News  

US FDA gives full approval to Moderna’s COVID vaccine The action by the Food and Drug Administration means the agency has completed the same rigorous, time-consuming review of Moderna’s shot as dozens of other long-established vaccines. Highlights Moderna's Covid vaccine has received full approval from the US Food and Drug Administration The vaccine, named Spikevax, is approved for use in …

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older
3 years, 1 month ago

Moderna's COVID-19 vaccine receives full FDA approval for Americans aged 18 and older

Daily Mail  

Moderna's COVID-19 vaccine has received full approval from the Food and Drug Administration for use in adults in the U.S., the company announced Monday. The Moderna COVID-19 vaccine has received full approval for use in adults from the FDA. Only the first two shots of Moderna's vaccine have received approval, and the booster shot remains available of the emergency use …

U.S. gives full approval to Moderna’s COVID-19 vaccine
3 years, 1 month ago

U.S. gives full approval to Moderna’s COVID-19 vaccine

LA Times  

U.S. regulators have granted full approval to Moderna’s COVID-19 vaccine after reviewing additional data on its safety and effectiveness. Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines. U.S. health regulators on Monday granted full approval to Moderna’s COVID-19 vaccine, a shot that’s already been given to tens of …

Booster shots needed against omicron, CDC studies show
3 years, 1 month ago

Booster shots needed against omicron, CDC studies show

Associated Press  

NEW YORK — Three studies released Friday offered more evidence that COVID-19 vaccines are standing up to the omicron variant, at least among people who received booster shots. The papers echo previous research — including studies in Germany, South Africa and the U.K. — indicating available vaccines are less effective against omicron than earlier versions of the coronavirus, but also …

Booster dose gives high levels of protection against infections from Omicron in older adults: UK study
3 years, 2 months ago

Booster dose gives high levels of protection against infections from Omicron in older adults: UK study

India Today  

A third top-up booster dose of a Covid-19 vaccine provides high levels of protection against severe disease from the Omicron variant among older adults, a latest UK study concluded on Saturday. The UK Health Security Agency analysis showed that around three months after the third jab, protection against hospitalisation among those aged 65 and over remains at about 90 per …

New COVID studies show promise for the Johnson & Johnson vaccine booster
3 years, 2 months ago

New COVID studies show promise for the Johnson & Johnson vaccine booster

NPR  

New COVID studies show promise for the Johnson & Johnson vaccine booster Enlarge this image toggle caption Rajesh Jantilal/AFP via Getty Images Rajesh Jantilal/AFP via Getty Images Two new studies of a Johnson & Johnson COVID-19 vaccine booster showed promise against the omicron variant at a time when public health officials are urgently recommending booster shots against the fast-spreading variant. …

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine
3 years, 2 months ago

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

Firstpost  

The panel cited the risk of rare but sometimes fatal cases of blood clotting as well as a lower level of effectiveness against COVID-19 in the Johnson & Johnson shot Washington: Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, United States health officials …

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s
3 years, 2 months ago

CDC recommends Pfizer, Moderna COVID-19 shots over J&J’s

Associated Press  

Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health officials said Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear more effective, said …

CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot
3 years, 2 months ago

CDC Panel Recommends Pfizer, Moderna Vaccines Over J&J Shot

Huff Post  

LOADING ERROR LOADING Most Americans should be given the Pfizer or Moderna vaccines instead of the Johnson & Johnson shot that can cause rare but serious blood clots, U.S. health advisers recommended Thursday. The strange clotting problem has caused nine confirmed deaths after J&J vaccinations — while the Pfizer and Moderna vaccines don’t come with that risk and also appear …

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine
3 years, 2 months ago

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine

Live Mint  

U.S. vaccine advisers are scheduled to consider whether to change recommendations on the use of Johnson & Johnson’s Covid-19 vaccine because of the risk of a rare but serious blood-clotting condition. The Advisory Committee on Immunization Practices will hear updates Thursday from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with …

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s
3 years, 3 months ago

US CDC panel votes to recommend mRNA COVID-19 vaccines over J&J’s

Al Jazeera  

The US had briefly paused use of the COVID jab in April, before finding benefit outweighs very rare, but deadly, risks. A panel of outside advisers to the US Centers for Disease Control and Prevention has voted to recommend Americans choose to receive one of the other two authorised COVID-19 vaccines over Johnson & Johnson’s shot, due to rare but …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years, 3 months ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

COVID-19 boosters on backburner for most pro sports leagues
3 years, 3 months ago

COVID-19 boosters on backburner for most pro sports leagues

Associated Press  

The push to get vaccine booster shots is not an immediate priority in most of the top sports leagues in North America even with delta and omicron variants spreading. “We’re not at that point yet,” NHLPA executive director Don Fehr said when asked about making boosters count as being fully vaccinated for the league’s approximately 700 players. “We’re doing whatever …

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds
3 years, 3 months ago

J&J Covid vaccine booster raised immune response after Pfizer vaccine, study finds

CNN  

CNN — Using the Johnson & Johnson vaccine as a booster for people initially immunized with the Pfizer/BioNTech vaccine produces a strong immune response and may do more to elicit protection against severe disease, researchers reported Sunday. Their small study of 65 volunteers who all initially got two doses of Pfizer/BioNTech’s vaccine showed that using the J&J Janssen vaccine as …

COVID-19 | Government to wait for expert view on booster dose, jabs for children
3 years, 3 months ago

COVID-19 | Government to wait for expert view on booster dose, jabs for children

The Hindu  

Any decision on COVID-19 vaccine booster dose or vaccines for children would be strictly based on the recommendations made by the expert committee looking into the matter. Applauding the work done by the scientific community and the medical staff, he stated that the nation had so far reported 3.46 crore COVID-19 cases and 4.6 lakh deaths. ‘Bold decisions taken’ The …

Protection offered by booster shot beats ‘natural immunity,’ study suggests
3 years, 3 months ago

Protection offered by booster shot beats ‘natural immunity,’ study suggests

LA Times  

Michael Stremfel prepares a COVID-19 booster shot at Flintridge Pharmacy in La Cañada Flintridge. A new study finds that people who got a booster shot generated much higher levels of neutralizing antibodies than people who had a coronavirus infection. A small study that’s among the first to track people’s protective antibodies over time found that those who were immunized against …

European Union Considers Booster Doses of J&J's Covid-19 Vaccine
3 years, 3 months ago

European Union Considers Booster Doses of J&J's Covid-19 Vaccine

News 18  

The European Medicines Agency says it is evaluating whether to authorize booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine. In a statement Monday, the EU drug regulator said it was considering an application from J&J to recommend booster doses of the J&J vaccine for adults 18 and over, at least two months after they were first immunized. The U.S. …

US expands Covid-19 booster eligibility to all adults
3 years, 3 months ago

US expands Covid-19 booster eligibility to all adults

India Today  

US regulators expanded eligibility for booster shots of Covid-19 vaccines to all adults on Friday, allowing millions more Americans to get additional protection against the virus amid a recent rise in infections. The director of the Centers for Disease Control and Prevention, Rochelle Walensky, signed off on the expanded eligibility on Friday evening after the US Food and Drug Administration …

Covid: Do vaccines wear off and why do we need booster jabs?
3 years, 4 months ago

Covid: Do vaccines wear off and why do we need booster jabs?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Covid US: 80% of J&J vaccine recipients are getting a Pfizer or Moderna booster
3 years, 4 months ago

Covid US: 80% of J&J vaccine recipients are getting a Pfizer or Moderna booster

Daily Mail  

Americans who received the Johnson & Johnson COVID-19 vaccine are not opting to get the shot again for their boosters, new federal figures reveal. Last month, the National Institutes of Health presented data showing that J&J recipients had higher antibody levels after a Pfizer or Moderna booster More than 80% of people who have received a COVID-19 booster, and got …

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds
3 years, 4 months ago

Johnson & Johnson's COVID-19 vaccine is 74% effective at preventing infection, study finds

Daily Mail  

Johnson & Johnson's COVID-19 vaccine is more than 70 percent effective at preventing infection, a new study finds. However, despite the effectiveness, the team still recommend people to get the Pfizer or Moderna vaccines if possible Researchers found that 0.7% of people vaccinated with the J&J vaccine contracted Covid during the study period, compared to 2.5% of unvaccinated people After …

New Jersey hospital becomes first to mandate BOOSTER shots for workers with J&J single dose vaccine
3 years, 4 months ago

New Jersey hospital becomes first to mandate BOOSTER shots for workers with J&J single dose vaccine

Daily Mail  

A New Jersey hospital has become the first to mandate booster shots for workers who have had the single-dose Johnson & Johnson vaccine. Elnahal made the announcement in a statement on October 27 Workers affected by the mandate could get the booster shot from J&J, or mix-and-match with Pfizer's, or half a dose of Moderna's More than 66percent of the …

Do You Need A Booster If You Had COVID And Got The Vaccine?
3 years, 4 months ago

Do You Need A Booster If You Had COVID And Got The Vaccine?

Huff Post  

Aja Koska via Getty Images Here's what experts say about getting a booster dose if you've already had COVID-19 and you're fully vaccinated. Here’s what we know now: First, people who’ve had COVID should definitely still get vaccinated — and get boosted, if they’re eligible. Meaning, if you’re in one of the eligible groups and it has been six months …

What you need to know about COVID boosters
3 years, 4 months ago

What you need to know about COVID boosters

NPR  

What you need to know about COVID boosters Enlarge this image toggle caption Alejandra Villa Loarca/Newsday via Getty Images Alejandra Villa Loarca/Newsday via Getty Images Millions of Americans can now opt for an extra shot of protection against COVID-19, regardless of which vaccine they initially received. Sponsor Message "People who have gotten a primary series of immunization — whatever it …

Which COVID-19 vaccine booster shot should I get? Here’s how to choose
3 years, 4 months ago

Which COVID-19 vaccine booster shot should I get? Here’s how to choose

LA Times  

Seniors at Whispering Fountains Senior Living Community in Lakewood get vaccinated in March. “It’s pretty unlikely that there is really a material difference in 35 versus 76 times higher,” Wachter said of the differences in antibody levels between Pfizer and Moderna boosters for original Johnson & Johnson recipients. The mix-or-match study found that people who originally got the Pfizer vaccine …

It’s OK to mix and match COVID-19 booster shoots. Which one should I get?
3 years, 4 months ago

It’s OK to mix and match COVID-19 booster shoots. Which one should I get?

LA Times  

Topping up your protection against severe COVID-19 while avoiding the risk of rare vaccine side effects should not be rocket science. But after at least 12 weeks of follow-up, researchers haven’t detected any ill effects in people who were first inoculated with one COVID-19 vaccine and then got a booster shot of another. The new study includes three groups of …

Pfizer's COVID-19 booster shot is safe, 95.6 percent effective against virus in patients 16 years and older
3 years, 4 months ago

Pfizer's COVID-19 booster shot is safe, 95.6 percent effective against virus in patients 16 years and older

Firstpost  

Several countries have already approved Covid-19 booster shots to increase immunity in people who have already been vaccinated, but whose protection may have dipped after several months, per some studies. A booster shot of the anti-Covid-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday. The clinical phase …

Discover Related